Directory
>
Ken Leslie
Ken Leslie
VP Business Development | Prime Medicine, Inc.
Boston, Massachusetts, United States
Ken Leslie
Summary
Ken Leslie is a seasoned professional with extensive experience in business development, particularly within the biotechnology and pharmaceutical sectors. As the current VP of Business Development at Prime Medicine, he leverages his strong background in finance and equity research to drive strategic initiatives. Ken holds an MBA from Columbia Business School, specializing in finance, and a BA in Molecular Biology from Kenyon College. His career spans various roles, including senior positions at Vertex Pharmaceuticals and Pacira Pharmaceuticals, showcasing his expertise in corporate strategy and external innovation. Ken's unique blend of scientific knowledge and financial acumen positions him as a leader in the intersection of healthcare and investment. He is passionate about advancing healthcare solutions and exploring innovative business strategies. Outside of work, Ken remains engaged with emerging trends in biotechnology and investment management.
Ken Leslie
Work Experience
VP Business Development at
Prime Medicine, Inc.
March 2022 - Present
Senior Director, Business Development - External Innovation at
Vertex Pharmaceuticals
September 2018 - March 2022
Director - Strategy and Corporate Development at
Pacira Pharmaceuticals
August 2016 - September 2018
Healthcare Therapeutics Analyst at
Goldwater Asset Management
November 2014 - April 2016
Analyst at
Suffolk Capital
April 2013 - November 2014
Healthcare Analyst at
Soros Fund Management
October 2009 - September 2012
Specialty Pharmaceuticals Equity Research - Summer Research Associate at
UBS
July 2009 - August 2009
Senior Research Associate at
Memorial Sloan Kettering Cancer Center
June 2001 - July 2008
Research Technician at
Gene Therapy Core Facility At Cornell University Medical School
August 1999 - August 2001
Ken Leslie
Education
Columbia Business School, Mba
January 2008 - January 2010
Kenyon College, Ba
January 1995 - January 1999
Frequently Asked Questions about Ken Leslie
What is Ken Leslie email address?
Ken Leslie's primary email address is *********@gsb.columbia.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ken Leslie work for?
Ken Leslie is a VP Business Development at Prime Medicine, Inc..
Where Ken Leslie graduated from?
Ken Leslie holds a degree in Finance from Columbia Business School.
How can I directly contact Ken Leslie?
To contact Ken Leslie directly, you can use the email address *********@gsb.columbia.edu. Complete contact information is available upon registration with Muraena.
Who is Ken Leslie?
Ken Leslie is a seasoned professional with extensive experience in business development, particularly within the biotechnology and pharmaceutical sectors. As the current VP of Business Development at Prime Medicine, he leverages his strong background in finance and equity research to drive strategic initiatives. Ken holds an MBA from Columbia Business School, specializing in finance, and a BA in Molecular Biology from Kenyon College. His career spans various roles, including senior positions at Vertex Pharmaceuticals and Pacira Pharmaceuticals, showcasing his expertise in corporate strategy and external innovation. Ken's unique blend of scientific knowledge and financial acumen positions him as a leader in the intersection of healthcare and investment. He is passionate about advancing healthcare solutions and exploring innovative business strategies. Outside of work, Ken remains engaged with emerging trends in biotechnology and investment management.
Ken`s contact details
*********@gsb.columbia.edu
*******@primemedicine.com
Colleagues
Chief Technical Officer
Vice President, Nonclinical Development at Prime Medicine
Venture Advisor
Chief HR Officer at Prime Medicine
Senior Vice President, Head of Strategy and Corporate Operations
Vice President
Chief Accounting Officer and SVP Finance
President and Chief Executive Office
Senior Vice President, Head of Regulatory Affairs
Vice President and Head of Hematology & Immunology